gammaglobulinemia and HIV infection [2, 3] . We report, to our knowledge, the first case of sustained bacteremia with C. jejuni in * Susceptibility is defined as ú1.0 log 10 , resistance as õ0.1 log 10 , and interan immunocompromised but completely asymptomatic patient.
mediate resistance as 0.1 -1.0 log 10 killing [5] .
A 53-year-old female with non-Hodgkin's lymphoma had bone marrow harvested before undergoing autologous bone marrow transplantation. She was asymptomatic. Findings on physical examination and results of laboratory studies were unremarkable.
Most strains of Campylobacter isolated from patients with gastrointestinal infections are susceptible to the bactericidal action of Serology for antibodies to HIV was negative.
A portion of the harvested bone marrow was purged of tumor normal human serum; isolates from patients with systemic infections are more often resistant to serum [5] . The ability of the cells by use of . A sample of the unpurged bone marrow was placed into a two-bottle host to limit campylobacter infection may be due in part to the susceptibility of C. jejuni to serum killing. The intermediate resis-BACTEC culture set (Becton Dickinson, Sparks, MD). Three days later, a curved gram-negative rod was detected in the aerobic bottle tance to normal serum killing seen in our patient may have been sufficient for the organism to cause sustained bacteremia. and was identified as C. jejuni. The patient was afebrile and still asymptomatic. There was no history of fever or gastrointestinal Finally, we detected C. jejuni in the harvested bone marrow as an incidental finding. We were unable to recover C. jejuni from tract symptoms. She denied recent travel or ingestion of undercooked seafood or meat. Blood cultures performed 5 days after the purged material; however, the organism remained viable in frozen samples of the original material. Whether 4HC has antithe bone marrow harvest yielded C. jejuni in all four bottles of the two culture sets. The results of cardiac examination were unrebacterial properties is unknown. The findings in this case add to the scope of disease due to markable, and echocardiography was not performed.
Susceptibility testing by agar dilution demonstrated MICs of C. jejuni by demonstrating that persistent bacteremia with C. jejuni may occur in the absence of signs or symptoms of infection. It is £0.5 mg/mL for ciprofloxacin and 0.5 mg/mL for erythromycin. On the day that the blood culture became positive, treatment was not clear whether the sustained asymptomatic bacteremia in this patient was a result of the organism's resistance to serum, to an started with erythromycin (500 mg po q.i.d.). Ciprofloxacin (500 mg b.i.d.) was substituted 2 days later because of gastrointestinal immunologic deficiency in the patient or a combination of these factors. intolerance. The patient completed a 3-week course of ciprofloxacin and then underwent a second bone marrow harvest. Cultures of the bone marrow were sterile. Two weeks later, she received an Mindy Schuster, Martin J. Blaser, and Irving Nachamkin infusion of 4HC-purged autologous bone marrow. Her subsequent 
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Molecular typing studies performed with use of flagellin gene Medical Center, Nashville, Tennessee typing by restriction fragment length polymorphism analysis of the Campylobacter flagellin gene flaA [4] revealed that all four isolates of C. jejuni (2 from blood, 1 from bone marrow, and 1 from frozen
